Form 4 for INSM INSMED Inc
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0001628280-24-000698 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-05 | 2024-01-03+ | INSM | Wise John Drayton | Chief Commercial Off | S - Sale+OE | $29.20 | -21.2K | 115.7K | -16% | -$620.1K |
| D | 2024-01-05 | 2024-01-04 | INSM | Wise John Drayton | Chief Commercial Off | A - Grant | — | +12.9K | 116.9K | +12% | — |
| D | 2024-01-05 | 2024-01-03 | INSM | Wise John Drayton | Chief Commercial Off | M - OptEx | $19.11 | +20.1K | 124.1K | +19% | +$383.6K |
| D | 2024-01-05 | 2024-01-03 | INSM | Wise John Drayton | Chief Commercial Off | M - OptEx | $0.00 | -20.1K | 0 | -100% | $0 |
| D | 2024-01-05 | 2024-01-04 | INSM | Wise John Drayton | Chief Commercial Off | A - Grant | $0.00 | +63.6K | 63.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Stock Option (right to buy) | 2024-01-03 | S | D | 20,071 | $29.19 | 103,984 | D | — | — | (F3) This is the weighted average sales price representing 20,071 shares sold at prices ranging from $28.915 to $29.39 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2024-01-05 | S | D | 1,167 | $29.32 | 115,690 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-04 | A | A | 12,873 | — | 116,857 | D | — | — | (F4) Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant. (F5) Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration. |
| 4 | Common | Stock Option (right to buy) | 2024-01-03 | M | A | 20,071 | $19.11 | 124,055 | D | — | — | (F2) Includes 1,303 shares acquired through the Company's 2018 Employee Stock Purchase Plan. |
| 5 | Derivative | Stock Option (right to buy) | 2024-01-03 | M | D | 20,071 | $0.00 | 0 | D | $19.11 · — to 2024-02-10 | 20,071 Common Stock | (F7) Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. |
| 6 | Derivative | Stock Option (right to buy) | 2024-01-04 | A | A | 63,560 | $0.00 | 63,560 | D | $29.13 · — to 2034-01-04 | 63,560 Common Stock | (F8) Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant. |